[ET Net News Agency, 6 March 2026] REMEGEN (09995) rose 10.3% to HK$84.8.
It hits an intra-day high of HK$84.8, breaking above the 100-D SMA of HK$84.658, and an intra-day low of HK$75.3. The total shares traded was 6.46 million, with a value of HK$531.01m. The active buy/sell ratio is 70:30, with net buying turnover of HK$204.65m. DBS VICKERS (HK) accounts for greatest net responsive buying turnover of HK$3.13m, with volume weighted average price of HK$82.653. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of HK$43.56m, with volume weighted average price of HK$82.509. The stock has risen a combined 18% over the past 2 consecutive trading days.
Basic Information| Nominal | 84.800 | % Chg | +10.27% |
| High | 84.800 | Low | 75.300 |
| Shares Tr | 6.46m | Turnover | 531.01m |
| 10-D SMA | 78.485 | %H.V | 46.671 |
| 20-D SMA | 79.655 | VWAP | 82.178 |
| 50-D SMA | 83.357 | RSI14 | 55.848 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 70:30, with net buying turnover of HK$204.65m, rising a combined 18% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 84.80 | +10.27 |
| HUTCHMED (00013) | 22.06 | +4.75 |
| INNOVENT BIO (01801) | 83.30 | +6.18 |
| XTALPI (02228) | 10.04 | +3.19 |
| WUXI BIO (02269) | 35.54 | +0.28 |
| WUXI APPTEC (02359) | 111.40 | +2.67 |
| TRANSTHERA-B (02617) | 89.90 | +40.25 |
| BEONE MEDICINES (06160) | 182.50 | +2.76 |
| DUALITYBIO-B (09606) | 306.60 | +5.29 |
| AKESO (09926) | 106.60 | +4.51 |
(ed)
